Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
Cartalax: Evidence Summary
Evidence summary for Cartalax across studied indications. Each indication is graded using our evidence tier system based on the quality and quantity of available clinical data.
Back to Cartalax overview| Indication | Evidence Tier | Trial Count | Summary |
|---|---|---|---|
| Osteoarthritis | Tier D | 0 | No human trials exist; rodent studies report reduced cartilage degeneration but remain unverified |
| Cartilage repair | Tier D | 0 | Animal data suggests chondrocyte effects but no human translation has been attempted |